Law360, New York (April 30, 2012, 9:24 PM ET) -- Retractable Technologies Inc.'s claim construction argument to the U.S. Supreme Court in seeking review of a ruling that its syringe patents are not infringed by Becton Dickinson & Co. undermines its arguments with regard to other key terms, Becton said last week.
Becton filed a conditional cross-petition for a writ of certiorari on April 23, urging the Supreme Court not to hear what it said is Retractable's meritless appeal arguing that the Federal Circuit incorrectly construed a key claim in the three patents it asserted against...
Becton Asks High Court To Refuse Retractable's IP Appeal
To view the full article, take a free trial now.
